Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Simultaneous Shingrix and FLUAD Vaccination
NCT05007041Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2021
- Primary completion
- Mar 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent, Zoster vaccine recombinant in influenza, herpes zoster (HZ), sponsored by Duke University. Started Sep 2021; status: completed.
02
Drugs
Fluzone TrivalentZoster vaccine recombinant
03
Conditions
influenzaherpes zoster (HZ)
Beyond the preview
Go deeper on NCT05007041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007041.